Excellon Announces Brokered Private Placement of Units for Gross Proceeds of up to C$5.0 Million, with a Lead Order from Eric Sprott

Stock Information for Acasti Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Acasti Pharma Inc.

Excellon Announces Appointment of Mike Hoffman to Board of Directors and Provides Corporate Update
Excellon Closes Acquisition of Mallay Silver Mine and Tres Cerros Gold/Silver Exploration Property in Peru
Excellon Announces Offtake and Financing with Glencore to Restart Mallay Silver Mine
Excellon Announces Closing of Brokered Private Placement of Units for Gross Proceeds of C$8.0 Million, Including Full Exercise of the Agents' Option and Lead Investment by Eric Sprott
Excellon Announces Transfer of Listing to TSX Venture Exchange
Excellon Announces Upsize of Brokered Private Placement of Units for Gross Proceeds of up to C$7.0 Million
Excellon Announces Upsize of Brokered Private Placement of Units for Gross Proceeds of up to C$6.5 Million
Excellon Announces Receipt of Statement of Claim

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.